Sanders and coworkers (2014) demonstrated the inactivation of IPF fibroblasts as well as the amelioration of experimental pulmonary fibrosis in response to global HDAC inhibition by SAHA [164]. Here, HDAC9 is linked to pulmonary fibrosis.